Guest Spotlight: Gerald Dryden Site Feasibility and Protocol Design

By Beth Davis Heppenstall on Fri, Feb 1, 2019 | 5 min read

BBK’s signature Pharma15 Live! web series is coming to the 10th Annual SCOPE Summit for Clinical Ops Executives. On February 19, Bonnie A. Brescia, BBK’s founding principal, will moderate a panel during the conference’s plenary keynote program on the topic of “Do Engagement Tools Live Up to Their Hype?” 

We are pleased to introduce one of our panelists, Gerald Wayne Dryden, Jr., MD, PhD, MSPH, MSc of University of Louisville, Kentucky.

Dr. Gerald Dryden

Dr. Gerald “Tad” Dryden is Professor of Medicine and Director of the Inflammatory Bowel Disease Program in the Division of Gastroenterology at the University of Louisville in Louisville, KY.  He earned his MD at the University of Kentucky College of Medicine in Lexington, KY, and completed his internal medicine internship and residency at the Naval Medical Center in Portsmouth, VA. He then completed his gastroenterology fellowship at the Naval Medical Center in San Diego, CA.  During his tenure at the University of Louisville, he earned a Master of Science in Public Health, a Master of Science in Microbiology and Immunology, and a PhD in Microbiology and Immunology. Dr. Dryden’s research interests include developing new therapies from botanical sources and new medical devices to improve endoscopic care.

What is most rewarding to you as you consider your contribution to clinical trial research?

It is very rewarding when I am involved with a drug from the ground up -- seeing research patients benefit from the drug, then eventually being able to prescribe it to my clinic patients.

Topics: Patient Recruitment, Patient Retention, Patient Engagement, Pharma15, Patient, Site Support, Physician Referrals, Patient Experience

Insights from Dr. Elliot Rosenstein: Referring Physicians in Clinical Trials

By BBK Worldwide on Wed, Jan 31, 2018 | 4 min read


For our latest eBook 21st Century Research Champions, we reached out to physicians to gain a deeper understanding about their attitudes and actions with regard to clinical research, and explored tested strategies in building relationships with physicians to enhance patient recuritment. As it turns out, physicians were more than happy to provide their insights into the value of referring physician programs and to elaborate on their willingness to contribute to clinical research. We interviwed Dr. Eliott Rosenstein -- a physician with more than 40 years of experience and Director of the Institute for Rheumatic and Autoimmune diseases -- to get his take on our latest eBook and the importance of referring physicians in clinical trial patient recruitment.

Topics: Physician Referrals, clinical research, clinical trials, Most Viewed

Part 3: Effective Physician-to-Physician Recruitment Programs

By Bonnie A. Brescia on Mon, Jul 31, 2017 | 3 min read

Part 1 in this series of blogs on the role of referring physicians in clinical research chronicled the factors that have led to study sponsors’ lack of confidence in physician referrals as an effective patient recruitment strategy. In Part 2 of this series on Research Champions referring physicians spoke for themselves through primary research conducted by BBK Worldwide. Today, we look at best practices that lead to referring physician programs that generate compelling results.

Topics: Physician Referrals, clinical research, clinical trials

Research Champions  Part 2: The Voice of Referring Physicians

By Bonnie A. Brescia on Wed, Jul 19, 2017 | 3 min read

Part 1 in this series of blogs on the role of referring physicians in clinical research chronicled the factors that have led to study sponsors’ lack of confidence in physician referrals as an effective patient recruitment strategy. This installment gives voice to the referring physicians themselves by sharing results of primary research conducted by BBK Worldwide.

Topics: Physician Referrals, clinical research, clinical trials

Research Champions Part 1: The Devolving Role of Referring Physicians

By Bonnie A. Brescia on Thu, Jul 13, 2017 | 2 min read

Long ago, in a land far away, principal investigators were expected to “accrue study subjects” using their network of physician colleagues. Enrolling subjects from one’s patient panel was discouraged as therapeutic misconception might impugn study results. As a result, acceptable enrollment might run from 36 to 60 months or more.

Investigators would commonly send a “Dear Doctor” letter to others within their hospital or to their personal connections. Rarely did these letters produce effective results. Over time, referring physician programs altogether lost value and credibility due to a few commonly held beliefs:



Topics: Patient Recruitment, Physician Referrals

Improve Research Study Feasibility and Investigator Selection

By BBKWorldwide on Tue, Nov 20, 2012 | 3 min read

Today’s blog is brought to you by Kris Sarajian at BioPharm Clinical. Last week, BioPharm Clinical teamed up with BBK Worldwide, a valued partner for nearly a decade, to deliver a joint webinar on how new types of patient data are helping clinical operations teams improve research study feasibility and investigator selection in order to maximize patient recruitment (In case you missed it, you can get the slides and watch a recording on the BioPharm website).

Topics: Physician Referrals, Physician Engagement, Site Selection

BBK Shop Talk: Referring Physician Toolkit

By Justin Jones on Fri, Sep 28, 2012 | 2 min read

Principal Investigators have vast amounts of time, money, and resources to find large numbers of potentially eligible patients to participate in their clinical research study,” said no one… ever. As clinical studies have become increasingly more competitive, more time-consuming, and more stringent in terms of eligibility criteria, it’s never been more important to provide PIs with easy-to-use tools that can inform, engage, and motivate.

Topics: Physician Referrals, Patient Recruitment

Summer’s heating up at

By Aaron Fleishman on Wed, Aug 1, 2012 | 3 min read

As if this summer wasn’t hot enough, we’re turning up the heat a little more by introducing exciting products and services during our Summer Sale. Each Monday we’ll be showcasing one product and delving a little deeper into how it can benefit the entire clinical research community. So, as we begin the month of August, here is a sneak peek at some of the products we’ll be showcasing.

Topics: Physician Referrals, Patient Recruitment, BBK Worldwide, Cultural Adaptation

Ring the Dinner Bell: Referring Physician Programs

By Karyn Besegai on Tue, Jul 10, 2012 | 3 min read

Co-Founder of BBK Worldwide Joan F. Bachenheimer wrote in a recent blog, “When options are limited, the medical community has an obligation to convey to patients the clinical trial options available to their patients.” Physicians play a crucial role in this and therefore it is important to foster relationships with them. Here’s an example of how.

Topics: Physician Referrals, Site Selection

Joan's Journal: What's In A Referral?

By Joan F. Bachenheimer on Mon, Apr 30, 2012 | 4 min read

Having played a significant role in recruiting patients to clinical trials for more years than I care to admit, I've learned a thing or two about how the medical community relates to the option of clinical trials for their patients. Here it goes:

Topics: BBK Worldwide, Patient Recruitment, Physician Referrals, Social Media, Site Selection

Subscribe To Our Blog